Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma
The aim of the present study was to investigate the significance of p53 and bcl-2 as prognostic factors among others in renal cell carcinoma patients. We evaluated the stages, histological grades, tumor diameters, cellular patterns and the presence of mutant p53 protein and bcl-2 overexpression in 5...
Gespeichert in:
| Veröffentlicht in: | Saudi medical journal 2005, Vol.26 (1), p.37-41 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 41 |
|---|---|
| container_issue | 1 |
| container_start_page | 37 |
| container_title | Saudi medical journal |
| container_volume | 26 |
| creator | UZUNLAR, Ali K SAHIN, Hayrettin YILMAZ, Fahri OZEKINCI, Selver |
| description | The aim of the present study was to investigate the significance of p53 and bcl-2 as prognostic factors among others in renal cell carcinoma patients.
We evaluated the stages, histological grades, tumor diameters, cellular patterns and the presence of mutant p53 protein and bcl-2 overexpression in 57 cases of renal cell carcinoma (RCC). Kaplan-Meier and log-rank tests estimated the survival function of each parameter. The study was carried out in the Department of Pathology and the Department of Urology, Faculty of Medicine, Dicle University Hospital, Diyarbakir, Turkey, in 2003.
The p53 mutation was 35% and bcl-2 overexpression incidence was 89.4% in the RCC cases included in the study. The 5-year disease specific survival rates of mutant p53 positive was 46.6% and p53 negative cases were 83.3%, (p=0.0063). There was no pathological parameter associated in bcl-2, and it has no prognostic significance.
The tumor stage, grade, diameter and p53 mutations affect the survival of RCC cases. The bcl-2 staining did not play any role to estimate patients at high risk of the disease progression. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_67497353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67497353</sourcerecordid><originalsourceid>FETCH-LOGICAL-p239t-efcd8cdac1ec4065fac1a44eb36c1cc153da75d1b03b28967ab54213887133c53</originalsourceid><addsrcrecordid>eNpFj09LxDAQxXNQ3HX1K0gueisknfxpTyLL6goLXvRcptMUKm1Sky3otzfiipc38-DHzHtnbC3A1oUuK7Vilym9CwHGCHPBVlJbbUCLNbvffc7RpTQEz0PPZw08eApzDEc3eI6-4y2NRcmzic7jyMmNWTDS4MOEV-y8xzG569PcsLfH3et2Xxxenp63D4diLqE-Fq6nrqIOSTpSwug-b6iUa8GQJJIaOrS6k62AtqxqY7HVqpRQVVYCkIYNu_u9m5N9LC4dm2lIP1HQu7CkxlhVW9CQwZsTuLST65o5DhPGr-avcgZuTwAmwrGP6GlI_5zJj0sl4Bthfl1U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67497353</pqid></control><display><type>article</type><title>Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>UZUNLAR, Ali K ; SAHIN, Hayrettin ; YILMAZ, Fahri ; OZEKINCI, Selver</creator><creatorcontrib>UZUNLAR, Ali K ; SAHIN, Hayrettin ; YILMAZ, Fahri ; OZEKINCI, Selver</creatorcontrib><description>The aim of the present study was to investigate the significance of p53 and bcl-2 as prognostic factors among others in renal cell carcinoma patients.
We evaluated the stages, histological grades, tumor diameters, cellular patterns and the presence of mutant p53 protein and bcl-2 overexpression in 57 cases of renal cell carcinoma (RCC). Kaplan-Meier and log-rank tests estimated the survival function of each parameter. The study was carried out in the Department of Pathology and the Department of Urology, Faculty of Medicine, Dicle University Hospital, Diyarbakir, Turkey, in 2003.
The p53 mutation was 35% and bcl-2 overexpression incidence was 89.4% in the RCC cases included in the study. The 5-year disease specific survival rates of mutant p53 positive was 46.6% and p53 negative cases were 83.3%, (p=0.0063). There was no pathological parameter associated in bcl-2, and it has no prognostic significance.
The tumor stage, grade, diameter and p53 mutations affect the survival of RCC cases. The bcl-2 staining did not play any role to estimate patients at high risk of the disease progression.</description><identifier>ISSN: 0379-5284</identifier><identifier>PMID: 15756350</identifier><identifier>CODEN: SAMJDI</identifier><language>eng</language><publisher>Riyadh: Saudi Medical Journal</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Carcinoma, Renal Cell - mortality ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic ; General aspects ; Humans ; Kidney Neoplasms - mortality ; Kidneys ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Prognosis ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Tumor Suppressor Protein p53 - genetics ; Tumors of the urinary system</subject><ispartof>Saudi medical journal, 2005, Vol.26 (1), p.37-41</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,4010</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16542240$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15756350$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>UZUNLAR, Ali K</creatorcontrib><creatorcontrib>SAHIN, Hayrettin</creatorcontrib><creatorcontrib>YILMAZ, Fahri</creatorcontrib><creatorcontrib>OZEKINCI, Selver</creatorcontrib><title>Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma</title><title>Saudi medical journal</title><addtitle>Saudi Med J</addtitle><description>The aim of the present study was to investigate the significance of p53 and bcl-2 as prognostic factors among others in renal cell carcinoma patients.
We evaluated the stages, histological grades, tumor diameters, cellular patterns and the presence of mutant p53 protein and bcl-2 overexpression in 57 cases of renal cell carcinoma (RCC). Kaplan-Meier and log-rank tests estimated the survival function of each parameter. The study was carried out in the Department of Pathology and the Department of Urology, Faculty of Medicine, Dicle University Hospital, Diyarbakir, Turkey, in 2003.
The p53 mutation was 35% and bcl-2 overexpression incidence was 89.4% in the RCC cases included in the study. The 5-year disease specific survival rates of mutant p53 positive was 46.6% and p53 negative cases were 83.3%, (p=0.0063). There was no pathological parameter associated in bcl-2, and it has no prognostic significance.
The tumor stage, grade, diameter and p53 mutations affect the survival of RCC cases. The bcl-2 staining did not play any role to estimate patients at high risk of the disease progression.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Renal Cell - mortality</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>General aspects</subject><subject>Humans</subject><subject>Kidney Neoplasms - mortality</subject><subject>Kidneys</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Prognosis</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumors of the urinary system</subject><issn>0379-5284</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFj09LxDAQxXNQ3HX1K0gueisknfxpTyLL6goLXvRcptMUKm1Sky3otzfiipc38-DHzHtnbC3A1oUuK7Vilym9CwHGCHPBVlJbbUCLNbvffc7RpTQEz0PPZw08eApzDEc3eI6-4y2NRcmzic7jyMmNWTDS4MOEV-y8xzG569PcsLfH3et2Xxxenp63D4diLqE-Fq6nrqIOSTpSwug-b6iUa8GQJJIaOrS6k62AtqxqY7HVqpRQVVYCkIYNu_u9m5N9LC4dm2lIP1HQu7CkxlhVW9CQwZsTuLST65o5DhPGr-avcgZuTwAmwrGP6GlI_5zJj0sl4Bthfl1U</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>UZUNLAR, Ali K</creator><creator>SAHIN, Hayrettin</creator><creator>YILMAZ, Fahri</creator><creator>OZEKINCI, Selver</creator><general>Saudi Medical Journal</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>2005</creationdate><title>Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma</title><author>UZUNLAR, Ali K ; SAHIN, Hayrettin ; YILMAZ, Fahri ; OZEKINCI, Selver</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p239t-efcd8cdac1ec4065fac1a44eb36c1cc153da75d1b03b28967ab54213887133c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Renal Cell - mortality</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>General aspects</topic><topic>Humans</topic><topic>Kidney Neoplasms - mortality</topic><topic>Kidneys</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Prognosis</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumors of the urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>UZUNLAR, Ali K</creatorcontrib><creatorcontrib>SAHIN, Hayrettin</creatorcontrib><creatorcontrib>YILMAZ, Fahri</creatorcontrib><creatorcontrib>OZEKINCI, Selver</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Saudi medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>UZUNLAR, Ali K</au><au>SAHIN, Hayrettin</au><au>YILMAZ, Fahri</au><au>OZEKINCI, Selver</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma</atitle><jtitle>Saudi medical journal</jtitle><addtitle>Saudi Med J</addtitle><date>2005</date><risdate>2005</risdate><volume>26</volume><issue>1</issue><spage>37</spage><epage>41</epage><pages>37-41</pages><issn>0379-5284</issn><coden>SAMJDI</coden><abstract>The aim of the present study was to investigate the significance of p53 and bcl-2 as prognostic factors among others in renal cell carcinoma patients.
We evaluated the stages, histological grades, tumor diameters, cellular patterns and the presence of mutant p53 protein and bcl-2 overexpression in 57 cases of renal cell carcinoma (RCC). Kaplan-Meier and log-rank tests estimated the survival function of each parameter. The study was carried out in the Department of Pathology and the Department of Urology, Faculty of Medicine, Dicle University Hospital, Diyarbakir, Turkey, in 2003.
The p53 mutation was 35% and bcl-2 overexpression incidence was 89.4% in the RCC cases included in the study. The 5-year disease specific survival rates of mutant p53 positive was 46.6% and p53 negative cases were 83.3%, (p=0.0063). There was no pathological parameter associated in bcl-2, and it has no prognostic significance.
The tumor stage, grade, diameter and p53 mutations affect the survival of RCC cases. The bcl-2 staining did not play any role to estimate patients at high risk of the disease progression.</abstract><cop>Riyadh</cop><pub>Saudi Medical Journal</pub><pmid>15756350</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0379-5284 |
| ispartof | Saudi medical journal, 2005, Vol.26 (1), p.37-41 |
| issn | 0379-5284 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67497353 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adult Aged Biological and medical sciences Carcinoma, Renal Cell - mortality Disease Progression Female Gene Expression Regulation, Neoplastic General aspects Humans Kidney Neoplasms - mortality Kidneys Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Prognosis Proto-Oncogene Proteins c-bcl-2 - genetics Tumor Suppressor Protein p53 - genetics Tumors of the urinary system |
| title | Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T03%3A38%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20p53%20oncoprotein%20and%20bcl-2%20in%20renal%20cell%20carcinoma&rft.jtitle=Saudi%20medical%20journal&rft.au=UZUNLAR,%20Ali%20K&rft.date=2005&rft.volume=26&rft.issue=1&rft.spage=37&rft.epage=41&rft.pages=37-41&rft.issn=0379-5284&rft.coden=SAMJDI&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E67497353%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67497353&rft_id=info:pmid/15756350&rfr_iscdi=true |